Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Shaalan Beg

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Digital Health|October 14, 2022
A qualitative study to explore the acceptability and usefulness of personalized biofeedback to motivate physical activity in cancer survivorsGrace E Brannon, Madison Ray, Patrick Cho, et al.
JAMA Network Open|February 16, 2022
A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder CancerMuhammet Ozer, Suleyman Y Goksu, Nina N Sanford, et al.
JCO Oncology Practice|June 24, 2020
Reply to S. Boutayeb et alEmil Lou, Muhammad Shaalan Beg, Emily Bergsland, et al.
American Journal of Clinical Oncology|August 2, 2017
A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal AdenocarcinomaJeffrey Meyer, Yull Arriaga, Joselin Anandam, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|August 2, 2021
Importance of addressing malnutrition in cancer and implementation of a quality improvement project in a gastrointestinal cancer clinicNicholas S Levonyak, Mary P Hodges, Nicole Haaf, et al.
JCO Oncology Practice|April 1, 2021
Implementation of a Quality Improvement Project to Increase Access to Dietitian Services for Patients With Gastrointestinal Cancer in a Safety-Net Hospital SystemNicholas S Levonyak, Mary P Hodges, Nicole Haaf, et al.
Cancers|September 9, 2020
Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine TumorSuleyman Yasin Goksu, Muhammet Ozer, Syed Mohammad Ali Kazmi, et al.
Cancer Medicine|June 8, 2022
Survival of cancer survivors with a new pancreatic cancer diagnosisSandi L Pruitt, Anna Tavakkoli, Hong Zhu, et al.
Cells|June 2, 2021
Expression of Immuno-Oncologic Biomarkers Is Enriched in Colorectal Cancers and Other Solid Tumors Harboring the A59T Variant of <i>KRAS</i>Emil Lou, Joanne Xiu, Yasmine Baca, et al.
Journal of Surgical Oncology|March 28, 2017
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancerMuhammad Shaalan Beg, Xiumei Huang, Molly A Silvers, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Digital Health|October 14, 2022
A qualitative study to explore the acceptability and usefulness of personalized biofeedback to motivate physical activity in cancer survivorsGrace E Brannon, Madison Ray, Patrick Cho, et al.
JAMA Network Open|February 16, 2022
A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder CancerMuhammet Ozer, Suleyman Y Goksu, Nina N Sanford, et al.
JCO Oncology Practice|June 24, 2020
Reply to S. Boutayeb et alEmil Lou, Muhammad Shaalan Beg, Emily Bergsland, et al.
American Journal of Clinical Oncology|August 2, 2017
A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal AdenocarcinomaJeffrey Meyer, Yull Arriaga, Joselin Anandam, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|August 2, 2021
Importance of addressing malnutrition in cancer and implementation of a quality improvement project in a gastrointestinal cancer clinicNicholas S Levonyak, Mary P Hodges, Nicole Haaf, et al.
JCO Oncology Practice|April 1, 2021
Implementation of a Quality Improvement Project to Increase Access to Dietitian Services for Patients With Gastrointestinal Cancer in a Safety-Net Hospital SystemNicholas S Levonyak, Mary P Hodges, Nicole Haaf, et al.
Cancers|September 9, 2020
Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine TumorSuleyman Yasin Goksu, Muhammet Ozer, Syed Mohammad Ali Kazmi, et al.
Cancer Medicine|June 8, 2022
Survival of cancer survivors with a new pancreatic cancer diagnosisSandi L Pruitt, Anna Tavakkoli, Hong Zhu, et al.
Cells|June 2, 2021
Expression of Immuno-Oncologic Biomarkers Is Enriched in Colorectal Cancers and Other Solid Tumors Harboring the A59T Variant of <i>KRAS</i>Emil Lou, Joanne Xiu, Yasmine Baca, et al.
Journal of Surgical Oncology|March 28, 2017
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancerMuhammad Shaalan Beg, Xiumei Huang, Molly A Silvers, et al.
Pageof 4